Filed with the SEC on · Summarized by InvestorsBot
Rachna Khosla, Amgen’s SVP of Business Development, sold 2,000 shares at $412.57 each on Aug. 11, for approximately $825,134, and 1,252 shares at $416.43 each on Aug. 13, for approximately $521,365. She owned 6,404 shares after each reported transaction; total open-market sales were approximately $1.35 million.
Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.
Subscribe freeAmgen SVP Derek Miller sells about $1.57M in stock
Form 4 · Insider Trade · August 7, 2026
Amgen SVP Nancy Grygiel sells about $1.2M in stock
Form 4 · Insider Trade · August 7, 2026
Amgen reports Q2 revenue growth and raises free cash flow to $3.5 billion
8-K · August 4, 2026
AMGEN filed an underwriting agreement dated Feb 17, 2026 — BofA Securities, Citigroup, J.P.
8-K · February 19, 2026
BREAKING: $AMGN sold $4.0B of senior notes across 2031/2036/2046/2056 maturities — net proceeds ≈ $3.961B.
8-K · February 19, 2026
AMGEN filed an 8-K (Item 9.01) on Feb 3, 2026 attaching a press release as Exhibit 99.1 (dated Feb 3, 2026).
8-K · February 3, 2026